(Q24243892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

title

Inhaled nitric oxide for respiratory failure in preterm infants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

N N Finer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

18 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

CD000509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

Inhaled nitric oxide in preterm infants undergoing mechanical ventilation

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

The safety and efficacy of nitric oxide therapy in premature infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Early inhaled nitric oxide therapy in premature newborns with respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide for premature infants with severe respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Nitric oxide for respiratory failure in infants born at or near term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Blood plasma alpha globulin fraction and antilymphocytic serum administered to mice. Effect on host reaction to graft and graft reaction to host (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide for respiratory failure in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Inhaled nitric oxide for respiratory failure in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

Bleeding time prolongation and NO inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhaled nitric oxide for premature infants after prolonged rupture of the membranes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Nitric oxide inhalation in infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000509.PUB3

7 January 2021

10.1002/14651858.CD000509.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17636641%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference